NEW YORK, Nov. 28 – Invitrogen has acquired the exclusive rights to develop and market genotyping products utilizing Orchid’s SNP-scoring primer extension technology in a 96-well format, the companies said Wednesday.

Under the terms of the deal, Invitrogen of San Diego will pay Orchid of Princeton, NJ, a royalty on kit sales. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.